ABSTRACT MUPS (Multi Unit Particulate System) of Didanosine were formulated using drug layering technique and were further compressed into tablets by using various excipients and polymers such as Micro crystalline cellulose in optimized amount to reduce the rupture of the enteric coating layer of MUPS. The Multi Unit Particulate System was prepared by drug layering onto the non pareil seeds followed by enteric coating. The prepared MUPS were found intact in simulated gastric fluid and released at intestinal pH. The controlled release of acid labile Didanosine from MUPS was influenced by the proportion of diluents added in tablet formulation to provide cushioning effect to MUPS. The release data evaluated by dissolution technique showed no release of drug at gastric pH and 100% release at intestinal pH.
INTRODUCTION
Solid dosage forms are widely prevalent, they hold a high potential as they serve to be most convenient for the administration of drugs. These have been developed into a wide range of formulations from conventional dosage forms for immediate release of the drug to controlled release dosage forms for the constant rate of drug release. Oral route is the most convenient and commonly used method of drug delivery. More than 50% of drug delivery systems available in the market are oral drug delivery systems. They offer convenience and ease of administration, greater flexibility in dosage forms have been used widely for decades mainly due to their convenience of administration and their suitability for delivery of drugs for systemic effects. The most commonly used pharmaceutical solid dosage forms today include granules, pellets, tablets and capsules. 1 Enteric coated dosage forms Enteric coated dosage forms are designed to resist the acidic environment of the stomach and to disintegrate in the higher pH environment of the intestinal fluid. Polymers for enteric coating can be applied to solid dosage forms (granules, pellets or tablets) from aqueous latex or pseudo latex dispersions, aqueous solutions of alkali salts or organic solvent solutions. Medication that causes incompatibilities in the stomach or irritates the gastric mucosa or provokes nausea and sickness can be coated with enteric films to pass the acid environment of the stomach unchanged and release the active drug only after entering the small intestine. Such coatings should also be used to protect acid sensitive drugs against aggressive gastric fluid. 
Review Article
Multi Unit Particulate System Multiparticulate systems are a plurality of granules or microspheres that can be loaded into either a capsule or tablets. Pelletization is an agglomeration process that converts fine powders or granules of bulk drugs and excipients into small, free flowing, spherical or semi spherical units, referred to as pellets. Pellets range in size, typically, between 0.5 to 1.5mm, though other sizes could be prepared depending on the processing technologies employed.
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Pellets are of great interest to the pharmaceutical industry for a variety of reasons. Pelletized products not only offer flexibility in dosage form design and development, but are also utilized to improve the safety and efficacy of bioactive agents. However, the single most important factor responsible for the proliferation of the pelletized products is the popularity of controlled release technology in the delivery of drugs. 5 When the pellets containing the active ingredient are administered in vivo in the form of suspensions, capsules or disintegrating tablets, they offer significant therapeutic advantages over single unit dosage forms. Because pellets disperse freely in the gastrointestinal tract, they invariably maximize drug absorption, reduce peak plasma fluctuations and minimize potential side effects without appreciably lowering drug bioavailability. Pellets also reduce variations in gastric emptying rates and overall transit times. Thus, intra and inter subject variability of plasma profiles, which are common with single unit regimens, are minimized.
5 Another advantage of pellets over single unit dosage forms is that high local concentrations of bioactive agents, which may inherently be irritative or anesthetic, can be avoided. When formulated as modified release dosage forms, pellets are less susceptible to dose dumping than the reservoir type, single unit formulations.
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Compaction of Multiparticulate oral Dosage forms
The design and development of multiparticulate dosage formulations in the form of compressed tablets rather than hard gelatin capsules are becoming increasingly important. 6 
Advantages of tablet dosage forms
Reduced cost Reduced liability to tampering Less prone to difficulties in esophageal transport than capsules Can be divided into two equal halves thus improving patient compliance in ingestion.
When a multiparticulate dosage product is developed in the form of a tablet, it is often desirable to produce compacts that disintegrate into many subunits soon after ingestion, to attain more uniform concentrations of active substances in the tact that the coated subunits in the formulation must withstand the process of compaction without being damaged, since, for e.g. the existence of a crack in the coating may have undesirable effects on the drug release properties of that subunit. The type and amount of coating agent, the size of the subunits, selection of the external additives, and the rate and magnitude of the pressure applied must be considered carefully to maintain the desired drug release properties of that subunit.
7
Particle rearrangement during compaction Prior to the penetration of the upper punch into the die, the particles flow with respect to each other, with the finer particles entering the voids between the larger ones, resulting in a closer packing arrangement. At this stage, the energy involved in the process is due to interparticulate friction, which define the number of contact points (i.e. potential binding areas) between the particles, are governed primarily by the density, size, size distribution, shape and surface properties of the individual particle as well as by the process variables, such as the rate of flow, and the relationship between the die cavity diameter and particle diameter. The packing characteristics of spherical, cubical, needlelike or filamentous particle are different.
Deformation of particles As the upper punch penetrates the die containing the powder bed, initially, there are essentially only points of contact between the particles. Utilizing the punches, application of an external force to the bed results in forces being transmitted through these interparticulate points of contact, where the stress is developed and local deformation of the material occurs. If there is any energy loss, it would be due to interparticulate and die wall friction as well as deformation of particles. The deformation will feature one or a combination of the following: elastic, plastic and /or fragmentation. The type of deformation depends on the rate and magnitude of the applied force as well as the duration of the locally induced stress and physical properties of the material. 
Research Envisaged
The use of Anti retroviral drugs has tremendously increased in the past decade. In the present study, Anti retroviral drugs i.e. Didanosine, Stavudine and Nevirapine have been selected as the model drugs on the basis of its pharmaceutical and pharmacokinetic considerations for the formation of Multi Unit Particulate System in tablet dosage form.
Challenges of research envisaged
MUPS in tablet dosage form shows the rupturing of the enteric coating layer during compression. Didanosine is acid labile hence given in enteric coated form. Didanosine has pH dependent solubility.
Usually MUPS are marketed as capsule of any and tablets of low strength drugs formulations. For Antiretroviral drugs, it's effective to go for combination therapy. Didanosine enteric coated pellets prepared by drug layering onto the sugar beads and to avoid rupturing of these pellets during compression it was proposed to select a suitable polymer and coating on to the drug loaded pellets, also the selection of the excipients providing elasticity to the blend for compression.
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EXPERIMENTAL
Step -1 Micronization of Didanosine Didanosine was micronized in Cadmach Air Jet mill, micronization was repeated twice to obtain very fine micronized drug.
Step-2 Drug Layering on Sugar Beads The drug layering and coating was performed in Glatt, type GPCG-1 fluidized bed coater with Wurster insert. The formula for the drug layering of Didanosine on NP seeds is shown below in Table 1   Table 1 : Formula for drug layering on NP Seeds
Equipment Information
Procedure HPMC E5 and SSG were dispersed in purified water and with stirring Didanosine was dispersed into the above. IPA was added to defoam the solution. The above dispersion was coated onto the NP seeds in GLATT GPCG-1.
Drug layering process
A fluidized bed granulator equipped with a 6 inch Wurster (bottom spray) insert was loaded with sugar beads. The dispersion was then sprayed on the beads moving in the apparatus. When the spraying process was completed, the drug layered beads were dried by further supplying dry air of 35°C for about 5-10min. The coated beads were then allowed to cool in the apparatus by supplying dry air at 20-25°C for about 10-15min.
Spray Rate: 20-25RPM Bed temperature: 34-36°C
Step -3 Enteric coating of pellets The formula for enteric coating on the drug loaded pellets is shown below in Table 2   Table 2 : Formula for enteric coating
Procedure
Eudragit L 30 D 55 dispersion was stirred and water was added to it. Added Propylene Glycol and stirred. pH was adjusted with sodium hydroxide 5% w/v solution to 5.0. The drug layered pellets were coated with Prepared Eudragit L 30 D 55 solution.
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Enteric Coating Process A fluidized bed granulator equipped with a 6 inch Wurster insert was loaded with drug layered pellets. The solution was then sprayed on the pellets fluidizing in the equipment. When the spraying process was completed the enteric coated pellets were dried by further supplying dry air of 35°C for about 5-10min. The coated pellets were then allowed to cool in the apparatus by supplying dry air of 20-25°C for about 10-15min.
Spray rate: 15-20RPM Bed temp: 35-37°C
The enteric coated pellets prepared seemed to be uniform but little agglomeration were found in the pellets, so talc and aerosil-200 were mixed to the enteric coated pellets.
Talc: 2mg/tab Aerosil 200: 2mg/tab
Step -4 Addition of other Antiretroviral drugs The other Antiretro viral drugs were added as granules along with the Didanosine pellets, the formula for preparation of granules in given in Table 3   Table 3 : Formula for Stavudine and Nevirapine granules Procedure Stavudine, Nevirapine, Lactose were sifted through #22 and mixed blend were granulated with 15% solution of PVP K-30. Added extra granular ingredients after sieving through #60.
The formula to prepare the tablet including Didanosine pellets and other anti retro viral drugs as granules in given in Table 4   Table 4 : Formula for Didanosine, Stavudine and Nevirapine tablets Procedure Weighed Didanosine enteric coated pellets, Stavudine and Nevirapine granules and mixed. Avicel 102, Ac Di Sol passed through #60 and mixed. The above blend was compressed on 22.5 × 10.5mm, concave, caplet punch.
Results
The assay of enteric coated pellets is given in Table 5 The results of Acid resistence of Didanosine pellets is given in Table 6 Table 6 : Acid Resistance (by HPLC)
The results of Dissolution analysis of Didanosine pellets in buffer is given in Table 7 The plot for Didanosine pellets % release Vs time is shown in Figure 1 The combination tablet prepared were observed for physical parameters, which is summarized in Table 8   Table 8 : Observations for prepared tablet
The assay result of combination tablet is given in Table 9   Table 9 : Assay of combination tablet (by HPLC)
The dissolution result of combination tablet is summarized in Table 10 The dissolution result of tablet in 6.8 pH phosphate buffer is given below in Table 11   Table 11 : Dissolution Analysis for Didanosine, Stavudine and Nevirapine tablets in 6.8 pH phosphate buffer after 2 hrs in 0.1N HCl
The plot of Didanosine % release Vs time from tablet is shown in Figure 2 The result of acid resistance of Didanosine pellets in combination tablet is given in Table 12   Table 12 : Acid Resistance of Didanosine
Discussion
Uniformly sized drug loaded pellets were obtained indicating that right amount of micronization and binder are available. Didanosine pellet showed 100% release in 60min. 10 This satisfactory result obtained by in vitro dissolution analysis by HPLC method. Also the assay and acid resistance result was satisfactory. Didanosine, Stavudine and Nevirapine tablet showed 100% release in 30min. This satisfactory result obtained by in-vitro dissolution analysis.
Conclusions
From the above results and discussions, it can be said that polymer selection and its % coating onto the drug layered sugar beads has reduced the polymer wall rupturing during compression of pellets due to the elasticity generated in the pellets. Also, the cushioning effect due to Avicel 102 and its concentration optimization has helped in compressing the pellets in combination with other anti retro viral drugs without any coating rupture.
